ArticleCrohn's & colitis 3602022

Case Series: Re-induction of Intravenous, Weight-Based Ustekinumab Is Well Tolerated in Patients With Moderate-Severe Crohn's Disease.

Scott David Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.